Vimpat is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Lacosamide.
Product ID | 70518-0257_835c102d-6a07-66ee-e053-2a91aa0aa630 |
NDC | 70518-0257 |
Product Type | Human Prescription Drug |
Proprietary Name | Vimpat |
Generic Name | Lacosamide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2017-02-23 |
Marketing Category | NDA / NDA |
Application Number | NDA022253 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | LACOSAMIDE |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
DEA Schedule | CV |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-02-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022253 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-02-23 |
Ingredient | Strength |
---|---|
LACOSAMIDE | 100 mg/1 |
SPL SET ID: | ce00e4d9-178b-4ae1-af76-4042f7e6c822 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0131-1810 | Vimpat | lacosamide |
0131-2470 | Vimpat | lacosamide |
0131-2477 | Vimpat | lacosamide |
0131-2478 | Vimpat | lacosamide |
0131-2479 | Vimpat | lacosamide |
70518-0257 | Vimpat | Vimpat |
0131-5410 | Vimpat | Vimpat |
0131-2480 | Vimpat | Vimpat |
70166-617 | Vimpat | Vimpat |
0121-0992 | Lacosamide | Lacosamide |
0121-1984 | Lacosamide | Lacosamide |
0121-2976 | Lacosamide | Lacosamide |
0121-3968 | Lacosamide | Lacosamide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VIMPAT 87195168 5351761 Live/Registered |
HARRIS FRC CORPORATION 2016-10-06 |
VIMPAT 79073055 3814774 Dead/Cancelled |
Harris FRC Corporation 2009-07-25 |
VIMPAT 77188576 3460602 Live/Registered |
HARRIS FRC CORPORATION 2007-05-23 |
VIMPAT 77016664 not registered Dead/Abandoned |
Schwarz Pharma Inc. 2006-10-09 |